Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al
Genet Med. 2022 Mar;24(3):744-746.
doi: 10.1016/j.gim.2021.10.020.
Epub 2021 Nov 30.
1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
2 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom; Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
3 British Heart Foundation Research Accelerator, and Institute of Health Informatics, University College London, London, United Kingdom.
4 Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
5 MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom.
6 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
7 British Heart Foundation Research Accelerator, and Institute of Health Informatics, University College London, London, United Kingdom; Bart's Heart Centre, Barts Health NHS Trust, St. Bartholomew's Hospital, London, United Kingdom.
8 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom; Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom. Electronic address: j.ware@imperial.ac.uk.